Prestige Consumer Healthcare market cap PBH

Share price times shares outstanding: what the whole company sells for, since 2011.

Prestige Consumer Healthcare is worth $2.3B at the close on Oct 23, 2026, at $47.80 a share.

That is down 26% over the last year and down 25% over five years.

Its highest close in our data was $4.4B in Mar 2025.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$2.3B	$2.1B	$3.3B	−25%
2025	$3B	$2.9B	$4.4B	−22%
2024	$3.9B	$2.9B	$4.2B	+28%
2023	$3B	$2.8B	$3.3B	−2%
2022	$3.1B	$2.5B	$3.2B	+2%
2021	$3B	$1.9B	$3.2B	+74%
2020	$1.7B	$1.5B	$2.3B	−14%
2019	$2B	$1.4B	$2B	+29%
2018	$1.6B	$1.5B	$2.4B	−33%
2017	$2.4B	$2.2B	$3B	−15%
2016	$2.8B	$2.4B	$3B	+2%
2015	$2.7B	$1.8B	$2.9B	+48%
2014	$1.8B	$1.4B	$1.8B	−1%
2013	$1.9B	$1B	$1.9B	+89%
2012	$982.3M	$565.4M	$1.1B	+73%
2011	$568.4M	$421.9M	$574.9M	n/a

Companies in Drug Manufacturers - General nearest Prestige Consumer Healthcare's size, closest first, today.

Company	Market cap
PBHPrestige Consumer Healthcare	$2.3B
HRMYHarmony Biosciences	$2.1B
NRIXNurix Therapeutics	$2.8B
ANIPANI Pharmaceuticals	$1.7B
PAHCPhibro Animal Health	$1.6B
ANABAnaptysbio	$1.5B
PCRXPacira BioSciences	$1.5B
OGNOrganon	$3.6B
LQDALiquidia	$3.8B
ARQTArcutis Biotherapeutics	$3.9B
INDVIndivior Pharmaceuticals	$4.1B
Peer median	$2.4B